|
| 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate Basic information |
Product Name: | 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate | Synonyms: | 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate;Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-, 1-(dihydrogen phosphate);Ethanol,2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-,dihydrogenphosphate(ester);GSK2983559 (compound 3);GSK2983559 free acid;inhibit,THP-1 cell,RIP kinase,GSK 2983559,GSK2983559 free acid,Inhibitor,GSK-2983559,RIPK,Receptor-interacting protein kinases,GSK-2983559 free acid,GSK2983559 | CAS: | 1579965-12-0 | MF: | C21H23N4O7PS2 | MW: | 538.53 | EINECS: | 604-604-1 | Product Categories: | | Mol File: | 1579965-12-0.mol | |
| 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate Chemical Properties |
Boiling point | 823.6±75.0 °C(Predicted) | density | 1.537±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMF: slightly soluble; DMSO: 1 mg/ml; PBS (pH 7.2): 1 mg/ml | form | A crystalline solid | pka | 1.76±0.10(Predicted) | color | Light yellow to yellow |
| 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate Usage And Synthesis |
| 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate Preparation Products And Raw materials |
|